All In Biotech

Free tool

FAERS Monitor: Ziagen

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020978 or its brand name (Ziagen, Abacavir Sulfate). Reports on generic versions are filed under their own applications.

Reports

4,037

Serious

3,693

91% of reports

Hospitalization

1,582

Death reported

501

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pain748
  • pyrexia501
  • hypertension425
  • anxiety419
  • hepatic enzyme increased410
  • emotional distress409
  • headache404
  • hypersensitivity399
  • off label use396
  • anhedonia368
  • fatigue367
  • exposure during pregnancy359
  • rash352
  • immunodeficiency328
  • nausea326

Reports by year received

View as table
YearReports
2004300
2005262
2006221
2007200
2008222
2009235
2010177
2011105
2012128
2013117
2014123
2015158
2016142
2017121
2018115
2019253
2020274
2021154
2022175
2023147
2024186
2025148
202674

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,122 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
immunodeficiencySignal328117.2105.536,863
anhedoniaSignal36874.067.126,082
hepatic enzyme increasedSignal41031.528.712,051
exposure during pregnancySignal35930.327.410,100
emotional distressSignal40917.716.16,426
hypersensitivitySignal39911.210.23,729
hypertensionSignal42510.59.63,662
anxietySignal4197.77.02,458
pyrexiaSignal5017.67.02,885
painSignal7486.46.03,464
rashSignal3524.23.8876
headacheSignal4043.43.1687
fatigueSignal3672.52.2327
off label useSignal3962.42.1321
nauseaSignal3262.11.9206

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.